Researchers are studying the mechanisms of adaptive resistance in cancer immunotherapy, exploring how cancer cells develop resistance to treatment. Various studies and reviews are investigating the complex dynamics of immune checkpoint blockade and tumor heterogeneity, as well as potential strategies to overcome resistance. New approaches, including targeting specific tumor-associated macrophages and migrastatic therapy, are being considered as possible ways to improve cancer treatment outcomes.